Increased Mortality and Cardiovascular Morbidity Associated With Use of Nonsteroidal Anti-inflammatory Drugs in Chronic Heart Failure | Zendy

Gunnar Gislason | Zendy; Jeppe Nørgaard Rasmussen | Zendy; Steen Z. Abildstrøm | Zendy; Tina Ken Schramm | Zendy; Morten Lock Hansen | Zendy; Emil Loldrup Fosbøl | Zendy; Rikke Sørensen | Zendy; Fredrik Folke | Zendy; Pernille Buch | Zendy; Niels Gadsbøll | Zendy; Søren Rasmussen | Zendy; Henrik E. Poulsen | Zendy; Lars Køber | Zendy; Mette Madsen | Zendy; Christian TorpPedersen | Zendy

Open Access

Increased Mortality and Cardiovascular Morbidity Associated With Use of Nonsteroidal Anti-inflammatory Drugs in Chronic Heart Failure

Author(s) -

Gunnar Gislason,

Jeppe Nørgaard Rasmussen,

Steen Z. Abildstrøm,

Tina Ken Schramm,

Morten Lock Hansen,

Emil Loldrup Fosbøl,

Rikke Sørensen,

Fredrik Folke,

Pernille Buch,

Niels Gadsbøll,

Søren Rasmussen,

Henrik E. Poulsen,

Lars Køber,

Mette Madsen,

Christian TorpPedersen

Publication year - 2009

Publication title -

archives of internal medicine

Language(s) - English

Resource type - Journals

eISSN - 1538-3679

pISSN - 0003-9926

DOI - 10.1001/archinternmed.2008.525

Subject(s) - medicine , myocardial infarction , hazard ratio , rofecoxib , diclofenac , celecoxib , heart failure , aspirin , proportional hazards model , confidence interval , anesthesia , biochemistry , chemistry , cyclooxygenase , enzyme

Accumulating evidence indicates increased cardiovascular risk associated with nonsteroidal anti-inflammatory drug (NSAID) use, in particular in patients with established cardiovascular disease. We studied the risk of death and hospitalization because of acute myocardial infarction and heart failure (HF) associated with use of NSAIDs in an unselected cohort of patients with HF.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research